Hepcidin expression in the liver of mice with implanted tumour reacts to iron deficiency, inflammation and erythropoietin administration

Folia Biologica (Czech Republic)

Volumn 57, Issue 6, 2011, Pages 248-254

  Vokurka, M ^a   Krijt, J ^a   Vavrova J ^a   Necas, E ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEPCIDIN; INTERLEUKIN 6; MESSENGER RNA; ANTIMICROBIAL CATIONIC PEPTIDE; IRON; TUMOR PROTEIN;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; INFLAMMATION; IRON DEFICIENCY; LIVER TUMOR; MALE; MELANOMA CELL; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VOLUME; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER; MELANOMA; METABOLISM; PATHOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANEMIA; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL PROLIFERATION; ERYTHROPOIETIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-6; IRON; LIVER; MALE; MELANOMA; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; RNA, MESSENGER; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84866243889     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Adamson, J. W. (2008) The anemia of inflammation/malignancy: mechanisms and management. Hematology Am. Soc. Hematol. Educ. Program 159-165.
2. Cucuianu, A., Patiu, M., Rusu, A. (2006) Hepcidin and multiple myeloma related anemia. Med. Hypotheses 66, 352-354.
3. Dicato, M., Plawny, L., Diederich, M. (2010) Anemia in cancer. Ann. Oncol. 21 (Suppl 7), vii167-vii172.
4. Ganz, T., Nemeth, E. (2009) Iron sequestration and anemia of inflammation. Semin. Hematol. 46, 387-393.
5. Grotto, H. Z. (2008) Anaemia of cancer: an overview of mechanisms involved in its pathogenesis. Med. Oncol. 25, 12-21.
6. Hohaus, S., Massini, G., Giachelia, M., Vannata, B., Bozzoli, V., Cuccaro, A., D'Alo, F., Larocca, L. M., Raymakers, R. A., Swinkels, D. W., Voso, M. T., Leone, G. (2010) Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin. J. Clin. Oncol. 28, 2538-2543.
7. Huang, H., Constante, M., Layoun, A., Santos, M. M. (2009) Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood 113, 3593-3599.
8. Jacober, M. L., Mamoni, R. L., Lima, C. S., Dos Anjos, B. L., Grotto, H. Z. (2007) Anaemia in patients with cancer: role of inflammatory activity on iron metabolism and severity of anaemia. Med. Oncol. 24, 323-329.
9. Kamai, T., Tomosugi, N., Abe, H., Arai, K., Yoshida, K. (2009) Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma. BMC Cancer 9, 270.
10. Katodritou, E., Dimopoulos, M. A., Zervas, K., Terpos, E. (2009a) Update on the use of erythropoiesis-stimulating agents (ESAs) for the management of anemia of multiple myeloma and lymphoma. Cancer Treat. Rev. 35, 738-743.
11. Katodritou, E., Ganz, T., Terpos, E., Verrou, E., Olbina, G., Gastari, V., Hadjiaggelidou, C., Varthaliti, M., Georgiadou, S., Westerman, M., Zervas, K. (2009b) Sequential evaluation of serum hepcidin in anemic myeloma patients: study of correlations with myeloma treatment, disease variables, and anemia response. Am. J. Hematol. 84, 524-526.
12. Kautz, L., Meynard, D., Monnier, A., Darnaud, V., Bouvet, R., Wang, R. H., Deng, C., Vaulont, S., Mosser, J., Coppin, H., Roth, M. P. (2008) Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 112, 1503-1509.
13. Kemna, E. H., Pickkers, P., Nemeth, E., van der Hoeven, H., Swinkels, D. (2005) Time-course analysis of hepcidin, se-rum iron, and plasma cytokine levels in humans injected with LPS. Blood 106, 1864-1866.
14. Kemna, E. H., Tjalsma, H., Willems, H. L., Swinkels, D. W. (2008) Hepcidin: from discovery to differential diagnosis. Haematologica 93, 90-97.
15. Kijima, H., Sawada, T., Tomosugi, N., Kubota, K. (2008) Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma. BMC Cancer 8, 167.
16. Krijt, J., Cmejla, R., Sykora, V., Vokurka, M., Vyoral, D., Necas. E. (2004) Different expression pattern of hepcidin genes in the liver and pancreas of C57BL/6N and DBA/2N mice. J. Hepatol. 40, 891-896.
17. Lou, D. Q., Nicolas, G., Lesbordes, J. C., Viatte, L., Grimber, G., Szajnert, M. F., Kahn, A., Vaulont, S. (2004) Functional differences between hepcidin 1 and 2 in transgenic mice. Blood 103, 2816-2821.
18. Mazur, A., Feillet-Coudray, C., Romier, B., Bayle, D., Gueux, E., Ruivard, M., Coudray, C., Rayssiguier, Y. (2003) Dietary iron regulates hepatic hepcidin 1 and 2 mRNAs in mice. Metabolism 52, 1229-1231.
19. Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., Ganz, T. (2004a) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113, 1271-1276.
20. Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., Kaplan, J. (2004b) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090-2093.
21. Nemeth, E., Ganz, T. (2009) The role of hepcidin in iron metabolism. Acta Haematol. 122, 78-86.
22. Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., Vaulont, S. (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. USA 98, 8780-8785.
23. Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., Vaulont, S. (2002a) The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110, 1037-1044.
24. Nicolas, G., Viatte, L., Bennoun, M., Beaumont, C., Kahn, A., Vaulont, S. (2002b) Hepcidin, a new iron regulatory peptide. Blood Cells Mol. Dis. 29, 327-335.
25. Pak, M., Lopez, M. A., Gabayan, V., Ganz, T., Rivera, S. (2006) Suppression of hepcidin during anemia requires erythropoietic activity. Blood 108, 3730-3735.
26. Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., Loreal, O. (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276, 7811-7819.
27. Pouckova, P., Soucek, J., Jelinek, J., Zadinova, M., Hlouskova, D., Polivkova, J., Navratil, L., Cinatl, J., Matousek, J. (1998) Antitumor action of bovine seminal ribonuclease. Cytostatic effect on human melanoma and mouse seminoma. Neoplasma 45, 30-34.
28. Sasu, B. J., Li, H., Rose, M. J., Arvedson, T. L., Doellgast, G., Molineux, G. (2010) Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI). Blood Cells Mol. Dis. 45, 238-245.
29. Sharma, S., Nemeth, E., Chen, Y. H., Goodnough, J., Huston, A., Roodman, G. D., Ganz, T., Lichtenstein, A. (2008) Involvement of hepcidin in the anemia of multiple myeloma. Clin. Cancer Res. 14, 3262-3267.
30. Tan, M. G., Kumarasinghe, M. P., Wang, S. M., Ooi, L. L., Aw, S. E., Hui, K. M. (2009) Modulation of iron-regulatory genes in human hepatocellular carcinoma and its physiological consequences. Exp. Biol. Med. (Maywood) 234, 693-702.
31. Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S. H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R. H., Eling, T. E., Childs, R., Ganz, T., Leitman, S. F., Fucharoen, S., Miller, J. L. (2007) High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat. Med. 13, 1096-1101.
32. Tanno, T., Porayette, P., Sripichai, O., Noh, S. J., Byrnes, C., Bhupatiraju, A., Lee, Y. T., Goodnough, J. B., Harandi, O., Ganz, T., Paulson, R. F., Miller, J. L. (2009) Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood 114, 181-186.
33. Theurl, I., Aigner, E., Theurl, M., Nairz, M., Seifert, M., Schroll, A., Sonnweber, T., Eberwein, L., Witcher, D. R., Murphy, A. T., Wroblewski, V. J., Wurz, E., Datz, C., Weiss, G. (2009) Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 113, 5277-5286.
34. Torrance, J. D., Bothwell, T. H. (1980) Tissue iron stores. Methods Hematol. 1, 90-115.
35. Tseng, H. H., Chang, J. G., Hwang, Y. H., Yeh, K. T., Chen, Y. L., Yu, H. S. (2009) Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications. J. Cancer Res. Clin. Oncol. 135, 1413-1420.
36. Ukarma, L., Johannes, H., Beyer, U., Zaug, M., Osterwalder, B., Scherhag, A. (2009) Hepcidin as a predictor of response to epoetin therapy in anemic cancer patients. Clin. Chem. 55, 1354-1360.
37. Vokurka, M., Krijt, J., Sulc, K., Necas, E. (2006) Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol. Res. 55, 667-674.
38. Ward, D. G., Roberts, K., Brookes, M. J., Joy, H., Martin, A., Ismail, T., Spychal, R., Iqbal, T., Tselepis, C. (2008) Increased hepcidin expression in colorectal carcinogenesis. World J. Gastroenterol. 14, 1339-1345.
39. Weinstein, D. A., Roy, C. N., Fleming, M. D., Loda, M. F., Wolfsdorf, J. I., Andrews, N. C. (2002) Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100, 3776-3781.
40. Weiss, G., Goodnough, L. T. (2005) Anemia of chronic disease. N. Engl. J. Med. 352, 1011-1023.
41. Weiss, G. (2009) Iron metabolism in the anemia of chronic disease. Biochim. Biophys. Acta 1790, 682-693.
42. Wrighting, D. M., Andrews, N. C. (2006) Interleukin-6 induces hepcidin expression through STAT3. Blood 108, 3204-3209.
43. Zhang, A. S., Enns, C. A. (2009) Molecular mechanisms of normal iron homeostasis. Hematology Am. Soc. Hematol. Educ. Program, 207-214.
44. Zucker, S. (2011) The swinging pendulum of the anemia of cancer: erythropoietin trumps hepcidin. J. Clin. Oncol. 29, e42.